Fate Therapeutics (FATE) Enterprise Value (2013 - 2026)
Fate Therapeutics' Enterprise Value was $161.27 million in Q2 2026, compared with -$94.42 million a year earlier.
Powered by 
Analysis
Fate Therapeutics (FATE) Enterprise Value (2013 - 2026) Analysis & Trends
For FY2025, Enterprise Value at Fate Therapeutics came in at -$90.6 million.
- In earlier years, Enterprise Value was -$91.09 million in FY2024, $53.69 million in FY2023 (-90.2%), $545.48 million in FY2022 (-89.1%) and $4.99 billion in FY2021 (-33.5%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q1 2024.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 199.6%); the worst was Q1 2023 (a decline of 95.2%).
- Per Business Quant data, FATE's Enterprise Value in the three quarters before Q2 2026 was -$35.27 million (Q1 2026), -$90.6 million (Q4 2025) and -$70.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161.27 Mn |
| Mar 31, 2026 | -35.27 Mn |
| Dec 31, 2025 | -90.60 Mn |
| Sep 30, 2025 | -70.10 Mn |
| Jun 30, 2025 | -94.42 Mn |
| Mar 31, 2025 | -149.89 Mn |
| Dec 31, 2024 | -91.09 Mn |
| Sep 30, 2024 | 101.67 Mn |
| Jun 30, 2024 | 68.55 Mn |
| Mar 31, 2024 | 451.74 Mn |
| Dec 31, 2023 | 53.69 Mn |
| Sep 30, 2023 | -140.73 Mn |
| Jun 30, 2023 | 91.03 Mn |
| Mar 31, 2023 | 150.79 Mn |
| Dec 31, 2022 | 545.48 Mn |
| Sep 30, 2022 | 1.67 Bn |
| Jun 30, 2022 | 1.83 Bn |
| Mar 31, 2022 | 3.17 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 4.97 Bn |
API Access
Fate Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();